| Summary of condensed balance sheet |
The
following is the condensed financial information of the Company on a parent company only basis.
Condensed
balance sheets
Summary
of condensed balance sheet
| | |
2026 | | |
2025 | |
| | |
As of March 31, | |
| | |
2026 | | |
2025 | |
| ASSETS | |
| | |
| |
| Current assets: | |
| | | |
| | |
| Cash and cash equivalents | |
$ | 862 | | |
$ | 207,511 | |
| Deferred expenses | |
| — | | |
| 52,500 | |
| Amounts due from subsidiaries | |
| 3,719,219 | | |
| 3,701,752 | |
| Amounts due from related parties | |
| - | | |
| 93,686 | |
| Investment in subsidiaries | |
| 4,344,752 | | |
| 10,595,038 | |
| TOTAL ASSETS | |
$ | 8,064,833 | | |
$ | 14,650,487 | |
| LIABILITIES | |
| | | |
| | |
| Current liabilities: | |
| | | |
| | |
| Amounts due to related parties | |
| — | | |
| 7,107 | |
| Interest payable | |
| 61,482 | | |
| | |
| Accrued expenses and liabilities | |
| 208,267 | | |
| 297,405 | |
| Promissory note to related parties | |
| 1,000,000 | | |
| 600,000 | |
| TOTAL LIABILITIES | |
$ | 1,269,749 | | |
$ | 904,512 | |
| | |
| | | |
| | |
| SHAREHOLDERS’ EQUITY: | |
| | | |
| | |
| Ordinary shares, par value $0.0002 per share, 500,000,000 shares authorized; 16,199,451 and 15,929,451 shares issued and outstanding as of March 31, 2026 and March 31, 2025, respectively | |
| 3,240 | | |
| 3,186 | |
| Preference shares, par value $0.0002 per share, 5,000,000 shares authorized; 1,000,000 and 0 shares issued and outstanding as of March 31, 2026 and March 31, 2025, respectively | |
| 200 | | |
| - | |
| Additional paid-in capital | |
| 19,072,173 | | |
| 17,872,227 | |
| Statutory reserve | |
| — | | |
| 40,590 | |
| Accumulated deficit | |
| (12,690,751 | ) | |
| (4,232,288 | ) |
| Accumulated other comprehensive income | |
| 410,222 | | |
| 62,260 | |
| TOTAL SHAREHOLDERS’ EQUITY | |
$ | 6,795,084 | | |
$ | 13,745,975 | |
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | |
$ | 8,064,833 | | |
$ | 14,650,487 | |
|
| Summary of condensed statements of income |
Condensed
statements of loss
Summary of condensed
statements of income
| | |
2026 | | |
2025 | | |
2024 | |
| | |
For the years ended March 31, | |
| | |
2026 | | |
2025 | | |
2024 | |
| Revenue | |
$ | — | | |
$ | — | | |
$ | — | |
| Cost of revenue | |
| — | | |
| — | | |
| — | |
| Gross profit | |
| — | | |
| — | | |
| — | |
| Operating expenses: | |
| | | |
| | | |
| | |
| General and administrative expenses | |
$ | (1,898,577 | ) | |
$ | (1,413,467 | ) | |
$ | (825,582 | ) |
| Share of loss in subsidiaries | |
| (6,548,341 | ) | |
| (6,155,143 | ) | |
| (4,629,554 | ) |
| Others, net | |
| (52,135 | ) | |
| (12,842 | ) | |
| 732,990 | |
| Provision for income tax | |
| — | | |
| — | | |
| — | |
| Net loss | |
$ | (8,499,053 | ) | |
$ | (7,581,452 | ) | |
$ | (4,722,146 | ) |
|
| Summary of Condensed Statements of Comprehensive Income |
Condensed
statements of comprehensive loss
Summary of Condensed
Statements of Comprehensive Income
| | |
2026 | | |
2025 | | |
2024 | |
| | |
For the years ended March 31, | |
| | |
2026 | | |
2025 | | |
2024 | |
| Net loss | |
$ | (8,499,053 | ) | |
$ | (7,581,452 | ) | |
$ | (4,722,146 | ) |
| Other comprehensive income/(loss) | |
| 347,962 | | |
| 107,698 | | |
| (733,539 | ) |
| Total comprehensive loss | |
$ | (8,151,091 | ) | |
$ | (7,473,754 | ) | |
$ | (5,455,685 | ) |
|
| Summary of Condensed Cash Flow |
Condensed
cash flow
Summary of Condensed
Cash Flow
| | |
2026 | | |
2025 | | |
2024 | |
| | |
For the years ended March 31, | |
| | |
2026 | | |
2025 | | |
2024 | |
| Net cash used in operating activities | |
$ | (606,950 | ) | |
$ | (624,183 | ) | |
$ | (966,510 | ) |
| Net cash used in investing activities | |
| — | | |
| — | | |
| — | |
| Net cash provided by financing activities | |
| 400,000 | | |
| 600,000 | | |
| — | |
| Net cash outflow | |
$ | (206,950 | ) | |
$ | (24,183 | ) | |
$ | (966,510 | ) |
|